L O Tjernberg1, A Pramanik, S Björling
1Laboratory of Biochemistry and Molecular Pharmacology, Section of Drug Dependence Research, Department of Clinical Neuroscience, the Karolinska Hospital, Stockholm, Sweden. Lars.Tjernberg@cmm.ki.se
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Alzheimer's disease involves amyloid beta-peptide (Abeta) aggregation. This study shows Abeta forms large aggregates before fibrils, a process inhibitable by Abeta ligands.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: